ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues

Noga Yerushalmi, Andrea Keppler-Hafkemeyer, George Vasmatzis, Xiu Fen Liu, Pär Olsson, Tapan K. Bera, Paul Duray, Byungkook Lee, Ira Pastan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We have identified a new gene, that is highly expressed in normal and neoplastic prostate, and is also expressed in cardiac atrium, salivary gland, spleen and selective cells in the CNS. Database analyses of ESTs indicated prostate specificity but experimental results showed the expression in other tissues. The full length transcript is 1800 bp with an open reading frame of 526 aa. The amino-terminal 230 residues of the expressed protein has high homology to a family of lectins, especially to the sugar binding domain of ERGIC-53. We therefore designate the new gene ERGL (ERGIC-53-like). There is a transmembrane domain at amino acid positions 468-482 suggesting that the product of ERGL is a type-I membrane protein. In prostate there are two fully processed transcripts one of which is a splice variant with a deletion in the region of the transmembrane domain of the protein.

Original languageEnglish (US)
Pages (from-to)55-60
Number of pages6
JournalGene
Volume265
Issue number1-2
DOIs
StatePublished - Mar 7 2001
Externally publishedYes

Fingerprint

Prostate
Genes
Expressed Sequence Tags
Salivary Glands
Lectins
Open Reading Frames
Membrane Proteins
Spleen
Databases
Amino Acids
Proteins
Protein Domains

Keywords

  • Alternate splicing
  • EST's data mining
  • In situ hybridization
  • Prostate cancer

ASJC Scopus subject areas

  • Genetics

Cite this

ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues. / Yerushalmi, Noga; Keppler-Hafkemeyer, Andrea; Vasmatzis, George; Liu, Xiu Fen; Olsson, Pär; Bera, Tapan K.; Duray, Paul; Lee, Byungkook; Pastan, Ira.

In: Gene, Vol. 265, No. 1-2, 07.03.2001, p. 55-60.

Research output: Contribution to journalArticle

Yerushalmi, N, Keppler-Hafkemeyer, A, Vasmatzis, G, Liu, XF, Olsson, P, Bera, TK, Duray, P, Lee, B & Pastan, I 2001, 'ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues', Gene, vol. 265, no. 1-2, pp. 55-60. https://doi.org/10.1016/S0378-1119(01)00347-X
Yerushalmi, Noga ; Keppler-Hafkemeyer, Andrea ; Vasmatzis, George ; Liu, Xiu Fen ; Olsson, Pär ; Bera, Tapan K. ; Duray, Paul ; Lee, Byungkook ; Pastan, Ira. / ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues. In: Gene. 2001 ; Vol. 265, No. 1-2. pp. 55-60.
@article{3c3f1823c3bf4cdb9a0a9a6d2e326247,
title = "ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues",
abstract = "We have identified a new gene, that is highly expressed in normal and neoplastic prostate, and is also expressed in cardiac atrium, salivary gland, spleen and selective cells in the CNS. Database analyses of ESTs indicated prostate specificity but experimental results showed the expression in other tissues. The full length transcript is 1800 bp with an open reading frame of 526 aa. The amino-terminal 230 residues of the expressed protein has high homology to a family of lectins, especially to the sugar binding domain of ERGIC-53. We therefore designate the new gene ERGL (ERGIC-53-like). There is a transmembrane domain at amino acid positions 468-482 suggesting that the product of ERGL is a type-I membrane protein. In prostate there are two fully processed transcripts one of which is a splice variant with a deletion in the region of the transmembrane domain of the protein.",
keywords = "Alternate splicing, EST's data mining, In situ hybridization, Prostate cancer",
author = "Noga Yerushalmi and Andrea Keppler-Hafkemeyer and George Vasmatzis and Liu, {Xiu Fen} and P{\"a}r Olsson and Bera, {Tapan K.} and Paul Duray and Byungkook Lee and Ira Pastan",
year = "2001",
month = "3",
day = "7",
doi = "10.1016/S0378-1119(01)00347-X",
language = "English (US)",
volume = "265",
pages = "55--60",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues

AU - Yerushalmi, Noga

AU - Keppler-Hafkemeyer, Andrea

AU - Vasmatzis, George

AU - Liu, Xiu Fen

AU - Olsson, Pär

AU - Bera, Tapan K.

AU - Duray, Paul

AU - Lee, Byungkook

AU - Pastan, Ira

PY - 2001/3/7

Y1 - 2001/3/7

N2 - We have identified a new gene, that is highly expressed in normal and neoplastic prostate, and is also expressed in cardiac atrium, salivary gland, spleen and selective cells in the CNS. Database analyses of ESTs indicated prostate specificity but experimental results showed the expression in other tissues. The full length transcript is 1800 bp with an open reading frame of 526 aa. The amino-terminal 230 residues of the expressed protein has high homology to a family of lectins, especially to the sugar binding domain of ERGIC-53. We therefore designate the new gene ERGL (ERGIC-53-like). There is a transmembrane domain at amino acid positions 468-482 suggesting that the product of ERGL is a type-I membrane protein. In prostate there are two fully processed transcripts one of which is a splice variant with a deletion in the region of the transmembrane domain of the protein.

AB - We have identified a new gene, that is highly expressed in normal and neoplastic prostate, and is also expressed in cardiac atrium, salivary gland, spleen and selective cells in the CNS. Database analyses of ESTs indicated prostate specificity but experimental results showed the expression in other tissues. The full length transcript is 1800 bp with an open reading frame of 526 aa. The amino-terminal 230 residues of the expressed protein has high homology to a family of lectins, especially to the sugar binding domain of ERGIC-53. We therefore designate the new gene ERGL (ERGIC-53-like). There is a transmembrane domain at amino acid positions 468-482 suggesting that the product of ERGL is a type-I membrane protein. In prostate there are two fully processed transcripts one of which is a splice variant with a deletion in the region of the transmembrane domain of the protein.

KW - Alternate splicing

KW - EST's data mining

KW - In situ hybridization

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0035819915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035819915&partnerID=8YFLogxK

U2 - 10.1016/S0378-1119(01)00347-X

DO - 10.1016/S0378-1119(01)00347-X

M3 - Article

C2 - 11255007

AN - SCOPUS:0035819915

VL - 265

SP - 55

EP - 60

JO - Gene

JF - Gene

SN - 0378-1119

IS - 1-2

ER -